Jacobs Levy Equity Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $553K | Sell |
9,244
-13,963
| -60% | -$835K | ﹤0.01% | 869 |
|
2025
Q1 | $1.22M | Buy |
23,207
+123
| +0.5% | +$6.46K | ﹤0.01% | 774 |
|
2024
Q4 | $1.27M | Sell |
23,084
-1,695
| -7% | -$93.2K | ﹤0.01% | 680 |
|
2024
Q3 | $1.25M | Buy |
24,779
+472
| +2% | +$23.7K | ﹤0.01% | 687 |
|
2024
Q2 | $1.07M | Buy |
24,307
+11,410
| +88% | +$501K | ﹤0.01% | 724 |
|
2024
Q1 | $567K | Sell |
12,897
-42
| -0.3% | -$1.85K | ﹤0.01% | 806 |
|
2023
Q4 | $614K | Sell |
12,939
-128
| -1% | -$6.08K | ﹤0.01% | 801 |
|
2023
Q3 | $580K | Sell |
13,067
-1
| -0% | -$44 | ﹤0.01% | 772 |
|
2023
Q2 | $624K | Buy |
+13,068
| New | +$624K | ﹤0.01% | 782 |
|
2019
Q2 | – | Sell |
-13,188
| Closed | -$370K | – | 984 |
|
2019
Q1 | $370K | Buy |
13,188
+4,780
| +57% | +$134K | 0.01% | 817 |
|
2018
Q4 | $206K | Buy |
+8,408
| New | +$206K | ﹤0.01% | 874 |
|